Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Zanganeh Maky
Relationship:   Chief Executive Office...
City:   Sunnyvale
State:   CA
   
Insider Summary:
  
   
Companies Owned :   3    
Direct Shares   1,125,725    

Indirect Shares

   198,074      
Direct Value   $12,419,888    

Indirect Value

   $2,455,959      
Total Shares   1,323,799      
Total Value   $14,875,847      


Pulse Biosciences, Inc. $8,492,950 Summit Therapeutics Inc $3,926,938 Pulse Biosciences, Inc. $8,492,950 Summit Therapeutics Inc $3,926,938
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    11   
    0    

     Stock price went up :
    10   
    0    
     Stock price went down :
    1   
    0    
   
     Gain/Loss Ratio :
   10.0   
   0.0   
     Percentage Gain/Loss :
   103.9%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Pharmacyclics Inc PCYC Chief Operating Officer 2015-05-26 0 2015-05-26 0    Premium*  
            Pulse Biosciences, Inc. PLSE Director 2023-11-13 604,911 2023-11-13 148,074    Premium*  
            Summit Therapeutics Inc SMMT Chief Executive Office... 2024-03-27 520,814 2024-03-27 50,000    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
PCYC Pharmacyclics Inc Chief Operating Officer   •       –      –    2015-05-26 4 D $261.25 $91,775,296 D/D (351,293) 0 0 -
SMMT Summit Therapeutics Inc Co-CEO & President   •       •      –    2023-03-08 4/A B $1.05 $24,703,396 I/I 23,527,044 9,884,095 2.66 -
PCYC Pharmacyclics Inc Chief Operating Officer   •       –      –    2015-05-26 4 D $261.25 $20,113,115 I/I (76,988) 0 0 -
SMMT Summit Therapeutics Inc Co-Chief Executive Officer   •       •      –    2023-03-08 4 B $1.05 $16,772,430 D/D 15,973,743 23,395,269 2.81 %
SMMT Summit Therapeutics Inc Co-Chief Executive Officer   •       •      –    2023-03-08 4 B $1.05 $7,930,966 I/I 7,553,301 9,884,095 2.66 %
PCYC Pharmacyclics Inc Chief Operating Officer   •       –      –    2015-03-11 4 S $254.11 $7,623,444 D/D (30,000) 225,312 0 -
SMMT Summit Therapeutics Inc Co-CEO & President   •       •      –    2022-08-16 4 B $0.97 $5,455,961 I/I 5,624,702 3,135,466 2.66 %
PCYC Pharmacyclics Inc Chief Operating Officer   •       –      –    2015-05-26 4 D $261.25 $3,918,750 D/D (15,000) 351,293 0 -
PCYC Pharmacyclics Inc Chief Operating Officer   •       –      –    2014-11-10 4 S $133.50 $3,078,027 D/D (23,000) 210,312 0 -
PCYC Pharmacyclics Inc Chief Operating Officer   •       –      –    2013-12-16 4 S $107.55 $2,151,000 D/D (20,000) 210,107 0 -
SMMT Summit Therapeutics Inc Chief Operating Officer   •       •      –    2021-05-12 4 B $5.24 $2,038,763 I/I 389,077 2,643,319 2.66 %
PCYC Pharmacyclics Inc Chief Operating Officer   •       –      –    2014-09-03 4 S $121.10 $850,980 D/D (7,000) 210,311 0 -
PCYC Pharmacyclics Inc Chief Operating Officer   •       –      –    2014-11-12 4 S $137.50 $818,216 D/D (5,931) 210,312 0 -
SMMT Summit Therapeutics Inc Chief Executive Officer   •       •      –    2023-12-11 4 OE $1.44 $705,332 D/D 489,814 489,814 0 -
PLSE Pulse Biosciences, Inc. Director   –       •      –    2017-05-09 4 B $20.16 $680,500 I/I 33,760 80,474 2.1 -
PCYC Pharmacyclics Inc Chief Operating Officer   •       –      –    2014-09-04 4 S $122.00 $610,000 D/D (5,000) 210,311 0 -
SMMT Summit Therapeutics Inc Chief Executive Officer   •       •      –    2023-12-11 4 OE $1.58 $498,776 I/I 315,681 24,889,479 0 -
PLSE Pulse Biosciences, Inc. Director   –       •      –    2017-08-03 4 B $23.23 $366,317 D/D 15,500 302,725 2.39 -
PLSE Pulse Biosciences, Inc. Director   –       •      –    2017-05-11 4 B $20.84 $312,540 D/D 15,000 278,935 2.39 -
PLSE Pulse Biosciences, Inc. Director   –       •      –    2017-09-14 4 B $12.23 $280,879 D/D 22,000 324,725 2.39 -
PCYC Pharmacyclics Inc Chief Operating Officer   •       –      –    2015-03-11 4 OE $7.19 $215,700 D/D 30,000 255,312 0 -
PLSE Pulse Biosciences, Inc. Director   –       •      –    2017-03-17 4 B $24.00 $215,004 I/I 8,960 42,434 2.1 -
PCYC Pharmacyclics Inc Chief Operating Officer   •       –      –    2014-11-07 4 S $135.01 $209,401 D/D (1,551) 210,312 0 -
PLSE Pulse Biosciences, Inc. Director   –       •      –    2017-08-02 4 B $25.15 $208,469 D/D 8,290 287,225 2.39 -
SMMT Summit Therapeutics Inc Chief Executive Officer   •       •      –    2024-03-27 4 B $3.71 $201,874 I/I 54,321 50,000 2.66 %
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us